Eikozanoidni receptor (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Eikozanoidni receptor" in Serbian language version.

refsWebsite

Global rank Serbian rank

4^th place

8^th place

2^nd place

4^th place

6^th place

5^th place

archive.org

DuBois RN, Gupta R, Brockman J, Reddy BS, Krakow SL, Lazar MA (1998). „The nuclear eicosanoid receptor, PPAR-γ, is aberrantly expressed in colonic cancers”. Carcinogenesis. 19 (1): 49—53. PMID 9472692. doi:10.1093/carcin/19.1.49.
Brink C, Dahlén SE, Drazen J, Evans JF, Hay DW, Nicosia S, Serhan CN, Shimizu T, Yokomizo T (2003). „International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors”. Pharmacol. Rev. 55 (1): 195—227. PMID 12615958. doi:10.1124/pr.55.1.8.
Brink C, Dahlén SE, Drazen J, Evans JF, Hay DW, Rovati GE, Serhan CN, Shimizu T, Yokomizo T (2004). „International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor”. Pharmacol. Rev. 56 (1): 149—57. PMID 15001665. doi:10.1124/pr.56.1.4.

DuBois RN, Gupta R, Brockman J, Reddy BS, Krakow SL, Lazar MA (1998). „The nuclear eicosanoid receptor, PPAR-γ, is aberrantly expressed in colonic cancers”. Carcinogenesis. 19 (1): 49—53. PMID 9472692. doi:10.1093/carcin/19.1.49.
Coleman RA, Smith WL, Narumiya S (1994). „International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes”. Pharmacol. Rev. 46 (2): 205—29. PMID 7938166.
Brink C, Dahlén SE, Drazen J, Evans JF, Hay DW, Nicosia S, Serhan CN, Shimizu T, Yokomizo T (2003). „International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors”. Pharmacol. Rev. 55 (1): 195—227. PMID 12615958. doi:10.1124/pr.55.1.8.
Brink C, Dahlén SE, Drazen J, Evans JF, Hay DW, Rovati GE, Serhan CN, Shimizu T, Yokomizo T (2004). „International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor”. Pharmacol. Rev. 56 (1): 149—57. PMID 15001665. doi:10.1124/pr.56.1.4.